{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:17:10Z","timestamp":1760908630948},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00404-010-1734-4","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T08:51:40Z","timestamp":1289897500000},"page":"981-988","source":"Crossref","is-referenced-by-count":10,"title":["Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line"],"prefix":"10.1007","volume":"284","author":[{"given":"Alexander","family":"Burges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mylonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"key":"1734_CR1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00130404-200309000-00004","volume":"9","author":"EL Franco","year":"2003","unstructured":"Franco EL, Schlecht NF, Saslow D (2003) The epidemiology of cervical cancer. Cancer J 9:348\u2013359","journal-title":"Cancer J"},{"key":"1734_CR2","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner SE (2003) Cervical cancer. Lancet 361:2217\u20132225. doi: 10.1016\/S0140-6736(03)13778-6","journal-title":"Lancet"},{"key":"1734_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien LT, Beauchemin MC, Thomas G (2010) Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 116:140\u2013146. doi: 10.1016\/j.ygyno.2009.09.040","journal-title":"Gynecol Oncol"},{"key":"1734_CR4","first-page":"CD007563","volume":"7","author":"X Wang","year":"2010","unstructured":"Wang X, Liu R, Ma B, Yang K, Tian J, Jiang L, Bai ZG, Hao XY, Wang J, Li J, Sun SL, Yin H (2010) High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev 7:CD007563. doi: 10.1002\/14651858.CD007563.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1734_CR5","doi-asserted-by":"crossref","unstructured":"Wang N, Guan QL, Wang K, Zhou X, Gao C, Yang HT, Ni TG (2010) Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet. doi: 10.1007\/s00404-010-1385-5 6","DOI":"10.1007\/s00404-010-1385-5"},{"key":"1734_CR6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550\u2013560. doi: 10.1038\/nrc2886","journal-title":"Nat Rev Cancer"},{"key":"1734_CR7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00404-008-0806-1","volume":"279","author":"E Barthell","year":"2009","unstructured":"Barthell E, Woelber L, Hellner K, Camerer B, Gieseking F, Hauschild M, Mylonas I, Friese K, Sings HL, Railkar R, Gause C, Barr E (2009) Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6\/11\/16\/18) vaccine. Arch Gynecol Obstet 279:803\u2013807. doi: 10.1007\/s00404-008-0806-1","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527. doi: 10.1056\/NEJMoa0216413","journal-title":"N Engl J Med"},{"key":"1734_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H zur Hausen","year":"2009","unstructured":"zur Hausen H (2009) Papillomaviruses in the causation of human cancers\u2014a brief historical account. Virology 384:260\u2013265. doi: 10.1016\/j.virol.2008.11.046","journal-title":"Virology"},{"key":"1734_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00404-009-1115-z","volume":"281","author":"CP Han","year":"2010","unstructured":"Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS (2010) Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study. Arch Gynecol Obstet 281:317\u2013323. doi: 10.1007\/s00404-009-1115-z","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00404-008-0859-1","volume":"280","author":"CC Yao","year":"2009","unstructured":"Yao CC, Kok LF, Lee MY, Wang PH, Wu TS, Tyan YS, Cheng YW, Kung MF, Han CP (2009) Ancillary p16(INK4a) adds no meaningful value to the performance of ER\/PR\/Vim\/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Arch Gynecol Obstet 280:405\u2013413. doi: 10.1007\/s00404-008-0859-1","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1315.023","volume":"1038","author":"W Vale","year":"2004","unstructured":"Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S (2004) Activins and inhibins and their signaling. Ann N Y Acad Sci 1038:142\u2013147","journal-title":"Ann N Y Acad Sci"},{"key":"1734_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","volume":"202","author":"Y Xia","year":"2009","unstructured":"Xia Y, Schneyer AL (2009) The biology of activin: recent advances in structure, regulation and function. J Endocrinol 202:1\u201312. doi: 10.1677\/JOE-08-0549","journal-title":"J Endocrinol"},{"key":"1734_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10735-009-9246-x","volume":"40","author":"F Bergauer","year":"2009","unstructured":"Bergauer F, Bruning A, Shabani N, Blankenstein T, Juckstock J, Dian D, Mylonas I (2009) Inhibin\/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines. J Mol Histol 40:353\u2013359. doi: 10.1007\/s10735-009-9246-x","journal-title":"J Mol Histol"},{"key":"1734_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00404-009-1310-y","volume":"282","author":"T Kimmich","year":"2010","unstructured":"Kimmich T, Bruning A, Kaufl SD, Makovitzky J, Kuhn C, Jeschke U, Friese K, Mylonas I (2010) Inhibin\/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line. Arch Gynecol Obstet 282:185\u2013191. doi: 10.1007\/s00404-009-1310-y","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR16","doi-asserted-by":"crossref","unstructured":"Kaufl SD, Kuhn C, Kunze S, Shabani N, Bruning A, Friese K, Mylonas I (2010) Inhibin\/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer. Arch Gynecol Obstet doi: 10.1007\/s00404-010-1614-y","DOI":"10.1007\/s00404-010-1614-y"},{"key":"1734_CR17","doi-asserted-by":"crossref","unstructured":"Gingelmaier A, Bruning A, Kimmich T, Makovitzky J, Bergauer F, Schiessl B, Friese K, Mylonas I (2010) Inhibin\/activin-betaE subunit is expressed in normal and pathological human placental tissue including chorionic carcinoma cell lines. Arch Gynecol Obstet doi: 10.1007\/s00404-009-1340-5","DOI":"10.1007\/s00404-009-1340-5"},{"key":"1734_CR18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1369\/jhc.2010.956185","volume":"58","author":"T Weissenbacher","year":"2010","unstructured":"Weissenbacher T, Bruning A, Kimmich T, Makovitzky J, Gingelmaier A, Mylonas I (2010) Immunohistochemical labeling of the inhibin\/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines. J Histochem Cytochem 58:751\u2013757. doi: 10.1369\/jhc.2010.956185","journal-title":"J Histochem Cytochem"},{"key":"1734_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/er.22.6.836","volume":"22","author":"GP Risbridger","year":"2001","unstructured":"Risbridger GP, Schmitt JF, Robertson DM (2001) Activins and inhibins in endocrine and other tumors. Endocr Rev 22:836\u2013858","journal-title":"Endocr Rev"},{"key":"1734_CR20","first-page":"1995","volume":"27","author":"I Mylonas","year":"2007","unstructured":"Mylonas I, Shabani N, Vogl J, Makovitzky J, Kunze S, Kuhn C, Schulze S, Friese K, Jeschke U (2007) Inhibin\/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles. Anticancer Res 27:1995\u20132000","journal-title":"Anticancer Res"},{"key":"1734_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10735-006-9029-6","volume":"37","author":"I Mylonas","year":"2006","unstructured":"Mylonas I, Schiessl B, Jeschke U, Vogl J, Makrigiannakis A, Kuhn C, Kunze S, Schulze S, Kainer F, Friese K (2006) Expression of inhibin\/activin subunits alpha (-alpha), beta A (-beta (A)) and beta B (-beta (B)) in placental tissue of normal and intrauterine growth restricted (IUGR) pregnancies. J Mol Histol 37:43\u201352","journal-title":"J Mol Histol"},{"key":"1734_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/EP:17:1:19","volume":"17","author":"I Mylonas","year":"2006","unstructured":"Mylonas I, Schiessl B, Jeschke U, Vogl J, Makrigiannakis A, Kuhn C, Schulze S, Kainer F, Friese K (2006) Expression of inhibin\/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic and HELLP pregnancies. Endocr Pathol 17:19\u201334","journal-title":"Endocr Pathol"},{"key":"1734_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00404-003-0526-5","volume":"268","author":"I Mylonas","year":"2003","unstructured":"Mylonas I, Jeschke U, Winkler L, Makovitzky J, Richter DU, Briese V, Friese K (2003) Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet 268:142\u2013150. doi: 10.1007\/s00404-003-0526-5","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00404-004-0666-2","volume":"272","author":"I Mylonas","year":"2005","unstructured":"Mylonas I, Makovitzky J, Fernow A, Richter DU, Jeschke U, Briese V, Gerber B, Friese K (2005) Expression of the inhibin\/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps. Arch Gynecol Obstet 272:59\u201366. doi: 10.1007\/s00404-004-0666-2","journal-title":"Arch Gynecol Obstet"},{"key":"1734_CR25","first-page":"97","volume":"17","author":"S Worbs","year":"2007","unstructured":"Worbs S, Shabani N, Mayr D, Gingelmaier A, Makrigiannakis A, Kuhn C, Jeschke U, Kupka MS, Friese K, Mylonas I (2007) Expression of the inhibin\/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: Possible immunohistochemical differentiation markers. Oncol Rep 17:97\u2013104","journal-title":"Oncol Rep"},{"key":"1734_CR26","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.ejca.2010.06.001","volume":"46","author":"I Mylonas","year":"2010","unstructured":"Mylonas I (2010) Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: Prognostic significance and clinical implications. Eur J Cancer 46:2485\u20132493. doi: 10.1016\/j.ejca.2010.06.001","journal-title":"Eur J Cancer"},{"key":"1734_CR27","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.83.4.1194","volume":"83","author":"F Petraglia","year":"1998","unstructured":"Petraglia F, Florio P, Luisi S, Gallo R, Gadducci A, Vigano P, Di Blasio AM, Genazzani AR, Vale W (1998) Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 83:1194\u20131200","journal-title":"J Clin Endocrinol Metab"},{"key":"1734_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00418-004-0709-6","volume":"122","author":"I Mylonas","year":"2004","unstructured":"Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS, Friese K (2004) Inhibin\/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol 122:461\u2013471","journal-title":"Histochem Cell Biol"},{"key":"1734_CR29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ejca.2009.01.008","volume":"45","author":"I Mylonas","year":"2009","unstructured":"Mylonas I, Worbs S, Shabani N, Kuhn C, Kunze S, Schulze S, Dian D, Gingelmaier A, Schindlbeck C, Bruning A, Sommer H, Jeschke U, Friese K (2009) Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin\/activin-alpha, -betaA and -betaB subunits in 302 cases. Eur J Cancer 45:1304\u20131314. doi: 10.1016\/j.ejca.2009.01.008","journal-title":"Eur J Cancer"},{"key":"1734_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2003.12.042","volume":"93","author":"I Mylonas","year":"2004","unstructured":"Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K (2004) Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Gynecol Oncol 93:92\u201397","journal-title":"Gynecol Oncol"},{"key":"1734_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0029-7844(98)00053-2","volume":"91","author":"T Otani","year":"1998","unstructured":"Otani T, Minami S, Kokawa K, Shikone T, Yamoto M, Nakano R (1998) Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 91:685\u2013692","journal-title":"Obstet Gynecol"},{"key":"1734_CR32","first-page":"2011","volume":"27","author":"A Gingelmaier","year":"2007","unstructured":"Gingelmaier A, Gutsche S, Mylonas I, Shabani N, Kuhn C, Kunze S, Jeschke U, Friese K (2007) Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin\/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma. Anticancer Res 27:2011\u20132017","journal-title":"Anticancer Res"},{"key":"1734_CR33","doi-asserted-by":"crossref","unstructured":"J\u00fcckstock K, Br\u00fcning A, Blankenstein T, Kunze S, Shaban N, Bergauer F, Mylonas I (2010) Immunolabeling of the inhibin-betaA and -betaB subunit in normal and malignant human cervical tissue and cervical cancer cell line. Int J Gynecol Cancer 20:1177\u20131125","DOI":"10.1111\/IGC.0b013e3181ef10aa"},{"key":"1734_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","volume":"7","author":"K Tsuchida","year":"2009","unstructured":"Tsuchida K, Nakatani M, Hitachi K, Uezumi A, Sunada Y, Ageta H, Inokuchi K (2009) Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal 7:15. doi: 10.1186\/1478-811X-7-15","journal-title":"Cell Commun Signal"},{"key":"1734_CR35","doi-asserted-by":"crossref","unstructured":"Blankenstein TJF, J\u00fcckstock JK, Shabani N, Kunze S, Br\u00fcning A, Bergauer F, Mylonas I (2010) Immunolabelling of the inhibin\/activin-betaC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines. Oncol Rep (in press)","DOI":"10.1111\/IGC.0b013e3181ef10aa"},{"key":"1734_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00418-009-0595-z","volume":"132","author":"A Bruning","year":"2009","unstructured":"Bruning A, Makovitzky J, Gingelmaier A, Friese K, Mylonas I (2009) The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells. Histochem Cell Biol 132:33\u201338. doi: 10.1007\/s00418-009-0595-z","journal-title":"Histochem Cell Biol"},{"key":"1734_CR37","doi-asserted-by":"crossref","unstructured":"Mylonas I (2010) Inhibin-betaA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation? Arch Gynecol Obstet doi: 10.1007\/s00404-010-1680-1","DOI":"10.1007\/s00404-010-1680-1"},{"key":"1734_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2004.02.015","volume":"225","author":"GP Risbridger","year":"2004","unstructured":"Risbridger GP, Ball EM, Wang H, Mellor SL, Peehl DM (2004) Re-evaluation of inhibin alpha subunit as a tumour suppressor in prostate cancer. Mol Cell Endocrinol 225:73\u201376","journal-title":"Mol Cell Endocrinol"},{"key":"1734_CR39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1349-7006.2006.00357.x","volume":"98","author":"S Ehata","year":"2007","unstructured":"Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K, Ishikawa Y, Nomura K, Yokoo H, Shimizu T, Ogata E, Miyazono K, Shimizu K, Imamura T (2007) Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci 98:127\u2013133","journal-title":"Cancer Sci"},{"key":"1734_CR40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1078-0432.CCR-07-1221","volume":"14","author":"H Ogino","year":"2008","unstructured":"Ogino H, Yano S, Kakiuchi S, Muguruma H, Ikuta K, Hanibuchi M, Uehara H, Tsuchida K, Sugino H, Sone S (2008) Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin Cancer Res 14:660\u2013667","journal-title":"Clin Cancer Res"},{"key":"1734_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/gyno.2000.5879","volume":"78","author":"J Farley","year":"2000","unstructured":"Farley J, Gray K, Nycum L, Prentice M, Birrer MJ, Jakowlew SB (2000) Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Gynecol Oncol 78:113\u2013122","journal-title":"Gynecol Oncol"},{"key":"1734_CR42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/360313a0","volume":"360","author":"MM Matzuk","year":"1992","unstructured":"Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313\u2013319","journal-title":"Nature"},{"key":"1734_CR43","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","volume":"91","author":"MM Matzuk","year":"1994","unstructured":"Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817\u20138821","journal-title":"Proc Natl Acad Sci USA"},{"key":"1734_CR44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI17788","volume":"112","author":"HB Adkins","year":"2003","unstructured":"Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M (2003) Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 112:575\u2013587","journal-title":"J Clin Invest"},{"key":"1734_CR45","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1158\/0008-5472.CAN-07-0805","volume":"67","author":"D Razanajaona","year":"2007","unstructured":"Razanajaona D, Joguet S, Ay AS, Treilleux I, Goddard-Leon S, Bartholin L, Rimokh R (2007) Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Cancer Res 67:7223\u20137229","journal-title":"Cancer Res"},{"key":"1734_CR46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2009.05.010","volume":"285","author":"A Ramachandran","year":"2009","unstructured":"Ramachandran A, Marshall ES, Love DR, Baguley BC, Shelling AN (2009) Activin is a potent growth suppressor of epithelial ovarian cancer cells. Cancer Lett 285:157\u2013165. doi: 10.1016\/j.canlet.2009.05.010","journal-title":"Cancer Lett"},{"key":"1734_CR47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2009.09.055","volume":"389","author":"I Katik","year":"2009","unstructured":"Katik I, Mackenzie-Kludas C, Nicholls C, Jiang FX, Zhou S, Li H, Liu JP (2009) Activin inhibits telomerase activity in cancer. Biochem Biophys Res Commun 389:668\u2013672. doi: 10.1016\/j.bbrc.2009.09.055","journal-title":"Biochem Biophys Res Commun"},{"key":"1734_CR48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/en.137.2.486","volume":"137","author":"N Di Simone","year":"1996","unstructured":"Di Simone N, Crowley WF Jr, Wang QF, Sluss PM, Schneyer AL (1996) Characterization of inhibin\/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137:486\u2013494","journal-title":"Endocrinology"},{"key":"1734_CR49","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1210\/en.139.3.1147","volume":"139","author":"N Di Simone","year":"1998","unstructured":"Di Simone N, Hall HA, Welt C, Schneyer AL (1998) Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Endocrinology 139:1147\u20131155","journal-title":"Endocrinology"},{"key":"1734_CR50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0303-7207(01)00648-7","volume":"192","author":"N Di Simone","year":"2002","unstructured":"Di Simone N, Schneyer AL, Caliandro D, Castellani R, Caruso A (2002) Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol. Mol Cell Endocrinol 192:187\u2013195","journal-title":"Mol Cell Endocrinol"},{"key":"1734_CR51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1541-7786.50.3.1","volume":"3","author":"MD Steller","year":"2005","unstructured":"Steller MD, Shaw TJ, Vanderhyden BC, Ethier JF (2005) Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells. Mol Cancer Res 3:50\u201361","journal-title":"Mol Cancer Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1734-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1734-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T06:30:38Z","timestamp":1685860238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1734-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1734-4","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,17]]}}}